2-61905693-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152516.4(COMMD1):āc.15G>Cā(p.Glu5Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000153 in 1,572,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152516.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COMMD1 | ENST00000311832.6 | c.15G>C | p.Glu5Asp | missense_variant | 1/3 | 1 | NM_152516.4 | ENSP00000308236.5 | ||
COMMD1 | ENST00000471704.1 | n.47G>C | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
COMMD1 | ENST00000445644.5 | n.47G>C | non_coding_transcript_exon_variant | 1/3 | 4 | |||||
COMMD1 | ENST00000472729.1 | n.119+16851G>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000152 AC: 3AN: 197304Hom.: 0 AF XY: 0.00000940 AC XY: 1AN XY: 106412
GnomAD4 exome AF: 0.00000704 AC: 10AN: 1420550Hom.: 0 Cov.: 31 AF XY: 0.00000712 AC XY: 5AN XY: 701908
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | The c.15G>C (p.E5D) alteration is located in exon 1 (coding exon 1) of the COMMD1 gene. This alteration results from a G to C substitution at nucleotide position 15, causing the glutamic acid (E) at amino acid position 5 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at